Legal & General Group’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.6K | Sell |
|
|||||
|
2025
Q1 | $38K | Sell |
|
|||||
|
2024
Q4 | $274K | Buy |
|
|||||
|
2024
Q3 | $445K | Buy |
|
|||||
|
2024
Q2 | $395K | Buy |
|
|||||
|
2024
Q1 | $53.8K | Sell |
|
|||||
|
2023
Q4 | $25.1K | Buy |
|
|||||
|
2023
Q3 | $18.4K | Sell |
|
|||||
|
2023
Q2 | $26.6K | Sell |
|
|||||
|
2023
Q1 | $22.2K | Sell |
|
|||||
|
2022
Q4 | $75.5K | Hold |
|
|||||
|
2022
Q3 | $223K | Sell |
|
|||||
|
2022
Q2 | $325K | Buy |
|
|||||
|
2022
Q1 | $119K | Hold |
|
|||||
|
2021
Q4 | $162K | Buy |
|
|||||
|
2021
Q3 | $282K | Buy |
|
|||||
|
2021
Q2 | $163K | Buy |
|
|||||
|
2021
Q1 | $137K | Buy |
|
|||||
|
2020
Q4 | $212K | Sell |
|
|||||
|
2020
Q3 | $166K | Sell |
|
|||||
|
2020
Q2 | $244K | Buy |
|
|||||
|
2020
Q1 | $118K | Sell |
|
|||||
|
2019
Q4 | $175K | Buy |
|
|||||
|
2019
Q3 | $88K | Hold |
|
|||||
|
2019
Q2 | $78K | Buy |
|
|||||
|
2019
Q1 | $28K | Hold |
|
|||||
|
2018
Q4 | $22K | Buy |
|